Purpose A telomerase reverse transcriptase (TERT) promoter mutation was identified in
thyroid cancer. This TERT promoter mutation is thought to be a prognostic molecular marker …

Background: The role of telomerase reverse transcriptase (TERT) promoter mutations in
differentiated thyroid cancer has been well established. These mutations have a significantly …

Background: Telomerase reverse transcriptase (TERT) promoter mutations have been found
in a subset of papillary thyroid carcinomas (PTCs) and are associated with tumor …

Objective Mutations in the telomerase reverse transcriptase (TERT) promoter have been
reported as a convincing prognostic factor in papillary thyroid carcinomas (PTCs). We aimed …

Background: Transcriptional activating mutations of telomerase reverse transcriptase (TERT)
are associated with more aggressive thyroid cancer. We evaluated the significance of TERT …

Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Tumor
recurrence occurs in∼ 20% of PTCs and some reach advanced stages. Promoter mutation …

The prognostic value of BRAF V600E and TERT promoter mutation in papillary thyroid
carcinoma (PTC) is controversial. We examined alterations in BRAF V600E and TERT …

Simple Summary TERT promoter mutation has recently emerged as a promising prognostic
biomarker for aggressive papillary thyroid cancer (PTC), along with BRAF B600E mutation …

Context Telomerase reverse transcriptase promoter (TERT-p) mutations, which upregulate
TERT expression, are strongly associated with tumor aggressiveness and worse prognosis …

Objective Transcriptional activating mutations in the promoter of the telomerase reverse
transcriptase (TERT) gene were reported at high frequency in aggressive poorly …